ConductScience.org, home

Paper39796705

Hepatotoxicity in Cancer Immunotherapy: Diagnosis, Management, and Future Perspectives.

Savino A and 5 others. Cancers (Basel), 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Hepatotoxicity in Cancer Immunotherapy: Diagnosis, Management, and Future Perspectives. Papers, record 39796705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39796705

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatotoxicity in Cancer Immunotherapy: Diagnosis, Management, and Future Perspectives.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.92, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Savino AAlberto
2Rossi AAlberto
3Fagiuoli SStefanohttps://orcid.org/0000-0001-8308-0701
4Invernizzi PPietrohttps://orcid.org/0000-0003-3262-1998
5Gerussi AAlessiohttps://orcid.org/0000-0002-5086-0514
6Viganò MMaurohttps://orcid.org/0000-0003-0769-1767

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
N/AItalian MUR Dipartimenti di Eccellenza 2023-2027 (l. 232/2016, art. 1, commi 314-337),PubMed
N/AItalian MUR PNRR PE06 "HEAL ITALIA - Health Extended Alliance for Innovative Therapies, Advanced Lab-research and Integrated Approaches of Precision Medicine" - Spoke 4 - Precision DiagnosticsPubMed
N/AItalian MUR PRIN 2022 PNRR P2022H7JYZ "Non-invasive biological and molecular characteri-zation of autoimmune liver diseases and variant syndromes'.PubMed

Source PubMed

Download CSV of grants

References218

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123408334Ipilimumab associated hepatitis: imaging and clinicopathologic findings.Invest New Drugs2013https://conductscience.org/library/papers/23408334PubMed
229371985Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors.Oncotarget2017https://conductscience.org/library/papers/29371985PubMed
329289977Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report.Cancer Immunol Immunother2018https://conductscience.org/library/papers/29289977PubMed
437567465Combination immune checkpoint therapy carried on despite grade 4 immune-related hepatotoxicity during treatment of metastatic melanoma: Case report and review of literature.Clin Res Hepatol Gastroenterol2023https://conductscience.org/library/papers/37567465PubMed
534115819Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy.PLoS One2021https://conductscience.org/library/papers/34115819PubMed
631929981Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients.Can J Gastroenterol Hepatol2019https://conductscience.org/library/papers/31929981PubMed
738954360Management and treatment of severe immune-related hepatotoxicity based on clinical and pathological characteristics.Hepatol Int2024https://conductscience.org/library/papers/38954360PubMed
833628621A multicenter characterization of hepatitis associated with immune checkpoint inhibitors.Oncoimmunology2021https://conductscience.org/library/papers/33628621PubMed
934482313Immune-related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and management.Eur J Gastroenterol Hepatol2021https://conductscience.org/library/papers/34482313PubMed
1029403081Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury.Mod Pathol2018https://conductscience.org/library/papers/29403081PubMed
1137889520Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.Hepatol Commun2023https://conductscience.org/library/papers/37889520PubMed
1231811095Pembrolizumab-induced autoimmune haemolytic anaemia and cholangitis.BMJ Case Rep2019https://conductscience.org/library/papers/31811095PubMed
1336747017Immune checkpoint inhibitor combinations-current and emerging strategies.Br J Cancer2023https://conductscience.org/library/papers/36747017PubMed
1436710655Association of immune-related adverse events and efficacy in advanced non-small-cell lung cancer: a systematic review and meta-analysis.Immunotherapy2023https://conductscience.org/library/papers/36710655PubMed
1538372756Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis.Eur J Clin Pharmacol2024https://conductscience.org/library/papers/38372756PubMed
1631656561Immunotherapy-related hepatitis: real-world experience from a tertiary centre.Frontline Gastroenterol2019https://conductscience.org/library/papers/31656561PubMed
1735575047Mycophenolate mofetil for immune checkpoint inhibitor-related hepatotoxicity relapsing during dose reduction of corticosteroid: A report of two cases and literature review.Cancer Rep (Hoboken)2022https://conductscience.org/library/papers/35575047PubMed
1828959504Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy.Curr Radiol Rep2016https://conductscience.org/library/papers/28959504PubMed
1933927311Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host disease.Sci Rep2021https://conductscience.org/library/papers/33927311PubMed
2028749795Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma: Natural Progression and Management.Am J Clin Oncol2018https://conductscience.org/library/papers/28749795PubMed

See all 218 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42792706Hepatic and Pancreatobiliary Immune-Related Adverse Events in Patients Receiving Immune Checkpoint Inhibitors: A Multidisciplinary Approach.Biomedicines2026https://conductscience.org/library/papers/42792706PubMed
41589213Nivolumab and bevacizumab attenuate cisplatin-induced hepatic inflammation and apoptosis in rats.Hepatol Forum2026https://conductscience.org/library/papers/41589213PubMed
41394868Metabolic collusion driving immune evasion in cholangiocarcinoma: unmasking the dual control of the immuno-metabolic microenvironment.Front Immunol2025https://conductscience.org/library/papers/41394868PubMed
40881884Clinical features and risk factors of immune-mediated liver injury in non-small cell lung cancer patients treated with immune checkpoint inhibitors.Front Oncol2025https://conductscience.org/library/papers/40881884PubMed
40868432Adolescent Survivors of Childhood Cancer: Biopsychosocial Challenges and the Transition from Survival to Quality of Life.Children (Basel)2025https://conductscience.org/library/papers/40868432PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39796705

GET https://conductscience.org/api/papers/v1/39796705/references?page=2